Law Times - Patrick Kierans

In the media October 2, 2017

Rejection of doctrine may encourage exaggerated claims

Patrick Kierans, who acted for intervenors Innovative Medicines Canada and BIOTECanada, comments on the AstraZeneca Canada Inc. v. Apotex Inc. Supreme Court of Canada decision and says we’re happy that the promise doctrine is gone.